Clinical Trial Update: Dopamine Neurotransmission in Major Depression

View source ↗

Summary

A completed clinical trial update from McLean Hospital examining dopamine neurotransmission in Major Depressive Disorder and Anhedonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia
• Major Depressive Disorder

Snippet

Sponsor: Mclean Hospital | Conditions: Major Depressive Disorder, Anhedonia | Status: COMPLETED